Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 9/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.43 |
| ▸ | MEN1 | O00255 | 4/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.43 |
| ▸ | HTT | P42858 | 3/20 | 0.43 |
| ▸ | GAA | P10253 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.38 |
| ▸ | POLB | P06746 | 2/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | AR | P10275 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | NPC1 | O15118 | 1/20 | 0.34 |
| ▸ | RAB9A | P51151 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 2/20 | 0.34 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL957304 | 0.90 | AR (0.39) | KDM4ESMN1; SMN2MEN1KMT2AHTT | |
| SCHEMBL195039 | 0.89 | KDM4E (0.41) | KDM4ESMN1; SMN2MEN1KMT2AHTT | |
| SCHEMBL14313368 | 0.84 | MAPT (0.41) | MEN1KMT2AGAAALDH1A1MAPT | |
| SCHEMBL7623767 | 0.83 | AR (0.36) | KDM4ESMN1; SMN2MEN1KMT2AHTT | |
| SCHEMBL9517525 | 0.82 | ALDH1A1 (0.36) | KDM4ESMN1; SMN2MEN1KMT2AHTT | |
| SCHEMBL959624 | 0.81 | ALDH1A1 (0.40) | KDM4ESMN1; SMN2MEN1KMT2AHTT | |
| SCHEMBL3789422 | 0.80 | ELANE (0.50) | SMN1; SMN2MEN1KMT2AHTTGAA | |
| SCHEMBL7633691 | 0.79 | KDM4E (0.37) | KDM4ESMN1; SMN2MEN1KMT2AHTT | |
| SCHEMBL17159499 | 0.79 | KDM4E (0.37) | KDM4ESMN1; SMN2MEN1KMT2AHTT | |
| SCHEMBL28402128 | 0.77 | KDM4E (0.42) | KDM4ESMN1; SMN2MEN1KMT2AHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 103 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230142648-A1 | OXIME ESTER PHOTOINITIATORS | BASF SE (DE) | 2023-05-11 | — | — | US | disclosed |
| EP-4114825-A1 | OXIME ESTER PHOTOINITIATORS | BASF SE (DE) | 2023-01-11 | — | — | EP | disclosed |
| CN-115210219-A | Oxime ester photoinitiators | 巴斯夫欧洲公司 | 2022-10-18 | — | — | CN | disclosed |
| US-20220121113-A1 | OXIME ESTER PHOTOINITIATORS HAVING A SPECIAL AROYL CHROMOPHORE | BASF SE (DE) | 2022-04-21 | — | — | US | disclosed |
| US-11209733-B2 | Oxime ester photoinitiators | BASF SE | 2021-12-28 | — | — | US | disclosed |
| US-11209734-B2 | Oxime ester photoinitiators | BASF SE | 2021-12-28 | — | — | US | disclosed |
| EP-3044208-B1 | OXIME ESTER PHOTOINITIATORS | BASF SE (DE) | 2021-12-22 | — | — | EP | disclosed |
| US-11204554-B2 | Oxime ester photoinitiators | BASF SE | 2021-12-21 | — | — | US | disclosed |
| EP-3914965-A1 | OXIME ESTER PHOTOINITIATORS HAVING A SPECIAL AROYL CHROMOPHORE | BASF SE (DE) | 2021-12-01 | — | — | EP | disclosed |
| CN-107652222-B | Oxime ester photoinitiators | 巴斯夫欧洲公司 | 2021-09-10 | — | — | CN | disclosed |
| EP-1963374-B1 | OXIME ESTER PHOTOINITIATORS | BASF SE (DE) | 2010-02-17 | — | — | EP | disclosed |
| EP-2144967-A2 | SURFACE-MODIFIED NANOPARTICLES COMPRISING A CATIONIC COLORANT FOR USE IN COLOR FILTERS | BASF SE (DE) | 2010-01-20 | — | — | EP | disclosed |
| US-7648738-B2 | for photopolymerization; photography, relief imaging; color filters | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2010-01-19 | — | — | US | disclosed |
| US-20090087759-A1 | Oxime Ester Photoinitiators | BASF SE (DE) | 2009-04-02 | — | — | US | disclosed |
| WO-2008107304-A2 | SURFACE-MODIFIED NANOPARTICLES COMPRISING A CATIONIC COLORANT FOR USE IN COLOR FILTERS | BASF SE (CH) | 2008-09-12 | — | — | WO | disclosed |
| US-20080081280-A1 | Use of Pyrimido[5,4-G] Pteridines as Shading Component in Color Filter Colorant Compositions | CIBA SPECIALTY CHEMICALS CORP. | 2008-04-03 | — | — | US | disclosed |
| EP-1778636-B1 | OXIME ESTER PHOTOINITIATORS | CIBA SC HOLDING AG (CH) | 2007-12-19 | — | — | EP | disclosed |
| EP-1794240-A1 | USE OF PYRIMIDO[5,4-G]PTERIDINES AS SHADING COMPONENT IN COLOR FILTER COLORANT COMPOSITIONS | Ciba Specialty Chemicals Holding Inc. (CH) | 2007-06-13 | — | — | EP | disclosed |
| US-20060241259-A1 | Oxime ester photoinitiators with heteroaromatic groups | CIBA CORPORATION | 2006-10-26 | — | — | US | disclosed |
| WO-2006037728-A1 | USE OF PYRIMIDO[5,4-G]PTERIDINES AS SHADING COMPONENT IN COLOR FILTER COLORANT COMPOSITIONS | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2006-04-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090087759-A1 | Oxime Ester Photoinitiators | CBR3, CCNE2, ALKBH2 | KDM4E 814/4885SMN1; SMN2 4449/4885MEN1 4410/4885 |
| US-11209734-B2 | Oxime ester photoinitiators | OR10J3, OXER1, QSOX1 | KDM4E 1549/4885SMN1; SMN2 4122/4885MEN1 2400/4885 |
| US-11204554-B2 | Oxime ester photoinitiators | OR10J3, OXER1, QSOX1 | KDM4E 1583/4885SMN1; SMN2 4185/4885MEN1 2447/4885 |
| US-11209733-B2 | Oxime ester photoinitiators | OR10J3, OXER1, QSOX1 | KDM4E 1549/4885SMN1; SMN2 4122/4885MEN1 2400/4885 |
| US-20230142648-A1 | OXIME ESTER PHOTOINITIATORS | OCIAD1, OCIAD2, OXER1 | KDM4E 1857/4885SMN1; SMN2 4082/4885MEN1 4834/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.